Human Rabies: A tragedy that must be prevented

  • DN Durrheim
  • GA Ogunbanjo Medunsa
  • L Blumberg University of Witwatersrand
  • R Spear James Cook University
  • GC Bishop
Keywords: Human rabies, South Africa, vaccination, immunoglobulin, post- exposure treatment

Abstract

Human rabies is endemic throughout South Africa and every year a number of deaths occur, mainly in children largely due to bites from infected dogs, coupled to incorrect management after the exposure.The encephalomyelitis that follows central nervous system invasion bythe rabies lyssavirus is invariably fatal. However modern vaccines and immunoglobulin registered for use in South Africa are safe and very effective in preventing rabies when administered correctly before and after exposure. Unfortunately the prohibitive cost of rabies vaccine does not allow for prophylactic routine immunisation of all children or indeed for the immunisation of all animal bke victims in South Africa.This article reviews current best practice in determining which persons should receive pre-exposure vaccination and post-exposure treatment. lt updates and expands the clinical guidelines for rabies management prepared by the South Africa Department of Health, briefly discussing specific principles of management. In addition, the confirmation of diagnosis and approach to patient care are described.

Author Biographies

DN Durrheim
MB, ChB, DTM&H, DCH, FACTM MPH &TM Communicable Disease Control, Mpumalanga Department of Health
GA Ogunbanjo, Medunsa
MB.BS, MFGP (SA), M Fam Med (MEDUNSA) Department of Family Medicine and Primary Health Care
L Blumberg, University of Witwatersrand
MB, BCh, DTM&H, DOH, DCH Dept. of Clinical Microbiology and Infectious Diseases, South African Institute for Medical Research & University of the Witwatersrand
R Spear, James Cook University
MB, BS, BVSc, PhD FACTM, FFPHM School of Public Health andTropic Medicine
GC Bishop
MSc Allerton Laboratory, Cascades
Section
Original Research